FDA approval of GLP-1 receptor agonist (liraglutide) for use in children

被引：27

作者：

Bacha, Fida ^{[1
]}

机构：

[1] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA

来源：

LANCET CHILD & ADOLESCENT HEALTH | 2019年 / 3卷 / 09期

关键词：

TYPE-2; METFORMIN;

D O I：

10.1016/S2352-4642(19)30236-6

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：595 / 597

页数：4

共 11 条

[1] Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutide [J].

Alatorre, Carlos ;

Lando, Laura Fernandez ;

Yu, Maria ;

Brown, Katelyn ;

Montejano, Leslie ;

Juneau, Paul ;

Mody, Reema ;

Swindle, Ralph .

DIABETES OBESITY & METABOLISM, 2017, 19 (07) :953-961

[2] Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association [J].

Arslanian, Silva ;

Bacha, Fida ;

Grey, Margaret ;

Marcus, Marsha D. ;

White, Neil H. ;

Zeitler, Philip .

DIABETES CARE, 2018, 41 (12) :2648-2668

[3] Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-cell Function in TODAY [J].

Arslanian, Silva ;

Pyle, Laura ;

Payan, Marisa ;

Bacha, Fida ;

Caprio, Sonia ;

Haymond, Morey W. ;

Levitsky, Lynne L. ;

Goland, Robin ;

White, Neil H. ;

Willi, Steven M. .

DIABETES CARE, 2013, 36 (06) :1749-1757

[4] Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry [J].

Bacha, Fida ;

Cheng, Peiyao ;

Gal, Robin L. ;

Kollman, Craig ;

Tamborlane, William V. ;

Klingensmith, Georgeanna J. ;

Manseau, Katherine ;

Wood, Jamie ;

Beck, Roy W. .

HORMONE RESEARCH IN PAEDIATRICS, 2018, 89 (01) :47-55

[5]

Davies MJ, 2018, DIABETES CARE, V41, P2669, DOI [10.2337/dci18-0033, 10.1007/s00125-018-4729-5]

[6] Metabolic Contrasts Between Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: I. Observations Using the Hyperglycemic Clamp [J].

Kahn, Steven E. ;

Arslanian, Silva A. ;

Buchanan, Thomas A. ;

Edelstein, Sharon L. ;

Ehrmann, David A. ;

Nadeau, Kristen J. ;

Palmer, Jerry P. ;

Utzschneider, Kristina M. .

DIABETES CARE, 2018, 41 (08) :1696-1706

[7] Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012 REPLY [J].

Mayer-Davis, Elizabeth J. ;

Dabelea, Dana ;

Lawrence, Jean M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (03) :301-301

[8]

RISE Consortium, 2019, DIABETES, DOI [10.2337/db19-0299, DOI 10.2337/DB19-0299]

[9] Liraglutide in Children and Adolescents with Type 2 Diabetes [J].

Tamborlane, William V. ;

Barrientos-Perez, Margarita ;

Fainberg, Udi ;

Frimer-Larsen, Helle ;

Hafez, Mona ;

Hale, Paula M. ;

Jalaludin, Muhammad Y. ;

Kovarenko, Margarita ;

Libman, Ingrid ;

Lynch, Jane L. ;

Rao, Paturi ;

Shehadeh, Naim ;

Turan, Serap ;

Weghuber, Daniel ;

Barrett, Timothy .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (07) :637-646

[10]

US FDA, 2019, FDA APPR NEW TREATM

← 1 2 →